- New Purchases: AMD, STE, DOV, ON, FB, CUE, APTO, INFN, QURE, STNG, EURN, INSW, NAT, RETA, SPWH, PRPL, NVDA, SFL, VRS, TCMD, RILY, NXRT, DHT, BKNG, AKTS, SIC,
- Added Positions: MA, UPLD, LOPE, TYL, CYRX, CRL,
- Reduced Positions: QNST, GLUU, NOW, MDT, FISV, OKTA,
- Sold Out: XLE, QQQ, GS, DRI, KOS, FIVN, ABT, MIK, BIG, BDN, AMTB, FRTA, DPZ,
For the details of Precept Management LLC's stock buys and sells, go to https://www.gurufocus.com/guru/precept+management+llc/current-portfolio/portfolio
These are the top 5 holdings of Precept Management LLC- Enterprise Products Partners LP (EPD) - 737,600 shares, 10.05% of the total portfolio.
- Tyler Technologies Inc (TYL) - 45,000 shares, 6.53% of the total portfolio.
- Tyler Technologies Inc (TYL) - 35,000 shares, 5.08% of the total portfolio. Shares added by 16.67%
- Amazon.com Inc (AMZN) - 5,000 shares, 4.47% of the total portfolio.
- Amazon.com Inc (AMZN) - 5,000 shares, 4.47% of the total portfolio.
Precept Management LLC initiated holding in Advanced Micro Devices Inc. The purchase prices were between $28.23 and $46.63, with an estimated average price of $37.13. The stock is now traded at around $55.31. The impact to a portfolio due to this purchase was 2.66%. The holding were 120,000 shares as of .
New Purchase: Steris PLC (STE)Precept Management LLC initiated holding in Steris PLC. The purchase prices were between $136.92 and $154.3, with an estimated average price of $146.84. The stock is now traded at around $168.51. The impact to a portfolio due to this purchase was 2.43%. The holding were 33,000 shares as of .
New Purchase: Dover Corp (DOV)Precept Management LLC initiated holding in Dover Corp. The purchase prices were between $91.99 and $115.85, with an estimated average price of $107.48. The stock is now traded at around $119.86. The impact to a portfolio due to this purchase was 1.96%. The holding were 35,200 shares as of .
New Purchase: ON Semiconductor Corp (ON)Precept Management LLC initiated holding in ON Semiconductor Corp. The purchase prices were between $17.12 and $24.55, with an estimated average price of $21.22. The stock is now traded at around $21.44. The impact to a portfolio due to this purchase was 1.77%. The holding were 150,000 shares as of .
New Purchase: Facebook Inc (FB)Precept Management LLC initiated holding in Facebook Inc. The purchase prices were between $174.6 and $208.1, with an estimated average price of $194.27. The stock is now traded at around $214.18. The impact to a portfolio due to this purchase was 1.35%. The holding were 13,600 shares as of .
New Purchase: Cue Biopharma Inc (CUE)Precept Management LLC initiated holding in Cue Biopharma Inc. The purchase prices were between $7.06 and $17.47, with an estimated average price of $10.63. The stock is now traded at around $17.35. The impact to a portfolio due to this purchase was 1.31%. The holding were 170,000 shares as of .
Added: Mastercard Inc (MA)Precept Management LLC added to a holding in Mastercard Inc by 173.68%. The purchase prices were between $260.85 and $300.74, with an estimated average price of $282.5. The stock is now traded at around $340.95. The impact to a portfolio due to this purchase was 2.38%. The holding were 26,000 shares as of .
Added: Upland Software Inc (UPLD)Precept Management LLC added to a holding in Upland Software Inc by 40.85%. The purchase prices were between $34.81 and $40.85, with an estimated average price of $37.37. The stock is now traded at around $44.60. The impact to a portfolio due to this purchase was 1%. The holding were 200,000 shares as of .
Added: Grand Canyon Education Inc (LOPE)Precept Management LLC added to a holding in Grand Canyon Education Inc by 95.24%. The purchase prices were between $84.42 and $100.63, with an estimated average price of $92.15. The stock is now traded at around $87.49. The impact to a portfolio due to this purchase was 0.93%. The holding were 41,000 shares as of .
Added: CryoPort Inc (CYRX)Precept Management LLC added to a holding in CryoPort Inc by 130.77%. The purchase prices were between $13.59 and $16.58, with an estimated average price of $14.89. The stock is now traded at around $18.67. The impact to a portfolio due to this purchase was 0.67%. The holding were 150,000 shares as of .
Added: Charles River Laboratories International Inc (CRL)Precept Management LLC added to a holding in Charles River Laboratories International Inc by 33.78%. The purchase prices were between $126.05 and $152.76, with an estimated average price of $138.94. The stock is now traded at around $176.48. The impact to a portfolio due to this purchase was 0.56%. The holding were 30,100 shares as of .
Sold Out: SPDR Select Sector Fund - Energy Select Sector (XLE)Precept Management LLC sold out a holding in SPDR Select Sector Fund - Energy Select Sector. The sale prices were between $55.9 and $61.99, with an estimated average price of $59.34.
Sold Out: PowerShares QQQ Trust Ser 1 (QQQ)Precept Management LLC sold out a holding in PowerShares QQQ Trust Ser 1. The sale prices were between $184.05 and $213.79, with an estimated average price of $200.68.
Sold Out: Goldman Sachs Group Inc (GS)Precept Management LLC sold out a holding in Goldman Sachs Group Inc. The sale prices were between $196.85 and $231.21, with an estimated average price of $217.51.
Sold Out: Darden Restaurants Inc (DRI)Precept Management LLC sold out a holding in Darden Restaurants Inc. The sale prices were between $108.01 and $119.83, with an estimated average price of $113.44.
Sold Out: Kosmos Energy Ltd (KOS)Precept Management LLC sold out a holding in Kosmos Energy Ltd. The sale prices were between $5.05 and $7.48, with an estimated average price of $6.03.
Sold Out: Five9 Inc (FIVN)Precept Management LLC sold out a holding in Five9 Inc. The sale prices were between $51.98 and $69.07, with an estimated average price of $61.52.
Here is the complete portfolio of Precept Management LLC. Also check out:
1. Precept Management LLC's Undervalued Stocks
2. Precept Management LLC's Top Growth Companies, and
3. Precept Management LLC's High Yield stocks
4. Stocks that Precept Management LLC keeps buying